drugset / Trial / NCT04010942

Vitamin D for Polycystic Ovary Syndrome Clomiphene Resistant Women

NCT04010942

Phase 4 Completed 120 enrolled Ain Shams University
RandomizedParallel-groupOpen-labelTreatment

Summary

This study is determining the therapeutic effect of Vitamin D supplements to Pcos clomiphene resistant polycystic ovarian syndrome Women. Half of patients will receive Vitamin D with metformin while other half metformin only. Then both groups start clomiphene for 3 month

Timeline

Start
2018-04-01
Primary completion
2018-12-30
Completion
2019-03-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Cholecalciferol Other / unclassified 100000 iu Intramuscular
Comparator Clomiphene Other / unclassified 100 mg Oral
Comparator Metformin Small molecule 2000 mg Oral